Summary
Ganglioside and DNA levels were estimated in the striatum of rats 10 days and 6 weeks after lesioning by intrastriatal injection of kainic acid. There was a moderate, 21–24% decrease of the ganglioside concentration per unit protein on the side of the lesion, which can be ascribed to the loss of the intrinsic striatal neurons following the injection of kainic acid. On the other hand, there was a 131 and 60% increase of DNA per unit protein in the kainate injected side 10 days and 6 weeks after the lesions, respectively; these changes apparently reflected the gliotic reaction brought about by the neurotoxin. Qualitatively similar findings — a decrease of ganglioside and an increase of DNA levels per unit protein — were also found in the brain of patients with Huntington's disease; however, as compared with the corresponding control material, the decrease of the ganglioside concentration was more pronounced in the striatum of Huntington's disease (by 38% in the caudate nucleus and by 46% in the putamen) than in the kainate lesioned rat striatum. This difference could be due to the different proportions of the intrinsic and extrinsic neuronal plasma membranes in the striatum of the two species; however, the possibility of a more generalized affection of neuronal plasma membranes in Huntington's disease may also be envisaged.
Similar content being viewed by others
References
Bernheimer H (1968) Ganglioside im Liquor cerebrospinalis und Tay-Sachssche Erkrankung. Klin Wochenschr 46: 258–261
Bernheimer H (1969) Zur Kenntnis der Ganglioside im Liquor cerebrospinalis des Menschen. Klin Wochenschr 47: 227–228
Bernheimer H, Sperk G, Price KS, Hornykiewicz O (1979) Brain gangliosides in Huntington's disease. Adv Neurol 23: 463–471
Coyle JT, Schwarcz R (1976) Lesion of striatal neurons with kainic acid provides a model for Huntington's chorea. Nature 263: 244–246
Coyle JT, McGeer EG, McGeer PL, Schwarcz R (1978) Neostriatal injections. A model for Huntington's Chorea, In: McGeer EG, Olney JW, McGeer PL (eds) Kainic acid as tool in neurobiology. Raven Press, New York, pp 139–159
Coyle JT, Molliver ME, Kuhar MJ (1978) In situ injection of kainic acid. A new method for selectively lesioning neuronal cell bodies while sparing axons of passage. J Comp Neurol 180: 301–324
Derry DM, Wolfe LS (1967) Gangliosides in isolated neurons and glial cells. Science 158: 1450–1452
Farley IJ, Hornykiewicz O (1977) Noradrenaline distribution in subcortical areas of the human brain. Brain Res 126: 53–62
Fishman PH, Brady RO (1976) Biosynthesis and function of gangliosides. Science 194: 906–915
Folch J, Lees M, Sloane-Stanley GH (1957) A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 226: 497–509
Hagberg B, Hultquist G, Öhman R, Svennerholm L (1965) Congenital amaurotic idiocy. Acta Paediatr Scand 54: 116–130
Hamberger A, Svennerholm L (1971) Composition of gangliosides and phospholipids of neuronal and glial cell enriched fractions. J Neurochem 18: 1821–1829
Karpiak SE, Graf L, Rapport MM (1976) Antiserum to gangliosides produces recurrent epileptiform activity. Science 194: 735–737
König JFR, Klippel RA (1963) The rat brain. A stereotaxic atlas for the forebrain and lower parts of the brain stem. Kriegen, Huntington New York
Kuhn R, Wiegandt H, Egge H (1961) Zum Bauplan der Ganglioside. Angew Chem 73: 580–581
Ledeen RW (1978) Ganglioside structures and distribution. Are they localized at the nerve ending? J Supramol Struct 8: 1–17
Ledeen RW, Skrivanek JA, Tirri LJ, Margolis RK, Margolis RU (1976) Gangliosides of the neuron. Localization and origin. Adv Exp Med Biol 71: 83–103
Lloyd KG, Farley IJ, Deck JHN, Hornykiewicz O (1974) Serotonin and 5-hydroxyindoleacetic acid in discrete areas of the brainstem of suicide victims and control patients. Adv Biochem Psychopharmacol 11: 387–397
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265–275
McGeer EG, McGeer PL (1976) Duplication of biochemical changes of Huntington's chorea by intrastriatal injections of glutamic and kainic acids. Nature 263: 517–519
Norton WT, Autilio LA (1966) The lipid composition of purified bovine brain myelin. J Neurochem 13: 213–222
Norton WT, Poduslo SE, Suzuki K (1966) Subacute sclerosing leukoencephalitis. II. Chemical studies including abnormal myelin and an abnormal ganglioside pattern. J Neuropathol Exp Neurol 25: 582–597
Norton WT, Poduslo SE (1971) Neuronal perikarya and astroglia of rat brain. Chemical composition during myelination. J Lipid Res 12: 84–90
Olney JW (1978) Neurotoxicity of excitatory amino acids. In: McGeer EG, Olney JW, McGeer PL (eds) Kainic acid as tool in neurobiology. Raven Press, New York, pp 95–122
Olney JW, de Gubareff T (1978) The fate of synaptic receptors in the kainate-lesioned striatum. Brain Res 140: 340–343
Poduslo SE, Norton WT (1972) Isolation and some chemical properties of oligodendroglia from calf brain. J Neurochem 19: 727–736
Sandhoff K, Christomanou H (1979) Biochemistry and genetics of gangliosidoses. Hum Genet 50: 107–143
Schwarcz R, Coyle JT (1977) Striatal lesions with kainic acid. Neurochemical characteristics. Brain Res 127: 235–249
Shatkin AJ (1969) Colorimetric reactions for DNA, RNA, and protein determinations. In: Habel K, Salzman NP (eds) Fundamental techniques in virology. Academic Press, New York, pp 231–237
Sperk G, Schlögl E (1979) Reduction of number of benzodiazepine binding sites in the caudate nucleus of the rat after kainic acid injections. Brain Res 170: 563–567
Suzuki K (1965) The pattern of mammalian brain gangliosides. II. Evaluation of the extraction procedures, post-mortem changes and the effect of formalin preservation. J Neurochem 12: 629–638
Suzuki K (1967) Ganglioside patterns of normal and pathological brains. In: Aronson SM, Volk BW (eds) Inborn disorders of sphingolipid metabolism. Pergamon Press, New York, pp 215–230
Suzuki K, Chen G (1966) Chemical studies on Jakob-Creutzfeldt disease. J Neuropathol Exp Neurol 25: 396–408
Svennerholm L (1957) Quantitative estimation of sialic acids. II. A colorimetric resorcinol-hydrochloric acid method. Biochem Biophys Acta 24: 604–611
Svennerholm L (1963) Chromatographic separation of human brain gangliosides. J Neurochem 10: 613–623
Tamai Y, Kojima H, Ikuta F, Kumanishi T (1978) Alterations in the composition of brain lipids in patients with Creutzfeldt- Jakob disease. J Neurol Sci 35: 59–76
Wherrett JR, Cumings JN (1963) Detection and resolution of gangliosides in lipid extracts by thin-layer chromatography. Biochem J 86: 378–382
Zaczek R, Schwarcz R, Coyle JT (1978) Long-term sequelae of striatal kainate lesion. Brain Res 152: 626–632
Author information
Authors and Affiliations
Additional information
The work was supported by Austrian Science Research Fund, Project No S-25
Rights and permissions
About this article
Cite this article
Higatsberger, M.R., Sperk, G., Bernheimer, H. et al. Striatal ganglioside levels in the rat following kainic acid lesions: Comparison with Huntington's disease. Exp Brain Res 44, 93–96 (1981). https://doi.org/10.1007/BF00238752
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00238752